<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:56:33Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4413743" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4413743</identifier><datestamp>2015-05-11</datestamp><setSpec>bmjgroup</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Med Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Med. Genet</journal-id>
      <journal-id journal-id-type="hwp">jmedgenet</journal-id>
      <journal-id journal-id-type="publisher-id">jmg</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medical Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0022-2593</issn>
      <issn pub-type="epub">1468-6244</issn>
      <publisher>
        <publisher-name>BMJ Publishing Group</publisher-name>
        <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4413743</article-id>
      <article-id pub-id-type="pmcid">PMC4413743</article-id>
      <article-id pub-id-type="pmc-uid">4413743</article-id>
      <article-id pub-id-type="pmid">25725044</article-id>
      <article-id pub-id-type="pmid">25725044</article-id>
      <article-id pub-id-type="publisher-id">jmedgenet-2014-102813</article-id>
      <article-id pub-id-type="doi">10.1136/jmedgenet-2014-102813</article-id>
      <article-categories>
        <subj-group subj-group-type="hwp-journal-coll">
          <subject>1506</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Genotype-Phenotype Correlations</subject>
        </subj-group>
        <series-title>Original article</series-title>
      </article-categories>
      <title-group>
        <article-title>De novo gain-of-function and loss-of-function mutations of <italic>SCN8A</italic> in patients with intellectual disabilities and epilepsy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Blanchard</surname>
            <given-names>Maxime G</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Willemsen</surname>
            <given-names>Marjolein H</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Walker</surname>
            <given-names>Jaclyn B</given-names>
          </name>
          <xref ref-type="aff" rid="af3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dib-Hajj</surname>
            <given-names>Sulayman D</given-names>
          </name>
          <xref ref-type="aff" rid="af4">4</xref>
          <xref ref-type="aff" rid="af5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Waxman</surname>
            <given-names>Stephen G</given-names>
          </name>
          <xref ref-type="aff" rid="af4">4</xref>
          <xref ref-type="aff" rid="af5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jongmans</surname>
            <given-names>Marjolijn CJ</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kleefstra</surname>
            <given-names>Tjitske</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>van de Warrenburg</surname>
            <given-names>Bart P</given-names>
          </name>
          <xref ref-type="aff" rid="af6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Praamstra</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="af6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nicolai</surname>
            <given-names>Joost</given-names>
          </name>
          <xref ref-type="aff" rid="af7">7</xref>
          <xref ref-type="aff" rid="af8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yntema</surname>
            <given-names>Helger G</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bindels</surname>
            <given-names>RenÃ© JM</given-names>
          </name>
          <xref ref-type="aff" rid="af1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meisler</surname>
            <given-names>Miriam H</given-names>
          </name>
          <xref ref-type="aff" rid="af3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kamsteeg</surname>
            <given-names>Erik-Jan</given-names>
          </name>
          <xref ref-type="aff" rid="af2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1">
<label>1</label><addr-line>Department of Physiology</addr-line>, <institution>Radboud Institute for Molecular Life Sciences, Radboud University Medical Center</institution>, <addr-line>Nijmegen</addr-line>, <country>The Netherlands</country></aff>
      <aff id="af2">
<label>2</label><addr-line>Department of Human Genetics</addr-line>, <institution>Radboud University Medical Center</institution>, <addr-line>Nijmegen</addr-line>, <country>The Netherlands</country></aff>
      <aff id="af3">
<label>3</label><addr-line>Department of Human Genetics</addr-line>, <institution>University of Michigan</institution>, <addr-line>Ann Arbor, Michigan</addr-line>, <country>USA</country></aff>
      <aff id="af4">
<label>4</label><institution>The Center for Neuroscience &amp; Regeneration Research, Yale School of Medicine</institution>, <addr-line>New Haven, Connecticut</addr-line>, <country>USA</country></aff>
      <aff id="af5">
<label>5</label><institution>The Rehabilitation Research Center, VA Connecticut Healthcare System</institution>, <addr-line>West Haven, Connecticut</addr-line>, <country>USA</country></aff>
      <aff id="af6">
<label>6</label><addr-line>Department of Neurology</addr-line>, <institution>Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center</institution>, <addr-line>Nijmegen</addr-line>, <country>The Netherlands</country></aff>
      <aff id="af7">
<label>7</label><addr-line>Department of Neurology</addr-line>, <institution>Maastricht University Medical Center</institution>, <addr-line>Maastricht</addr-line>, <country>The Netherlands</country></aff>
      <aff id="af8">
<label>8</label><institution>Epilepsy Center Kempenhaeghe</institution>, <addr-line>Heeze</addr-line>, <country>The Netherlands</country></aff>
      <author-notes>
        <corresp><label>Correspondence to</label> Dr Erik-Jan Kamsteeg, Department of Human Genetics, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands; <email>Erik-Jan.Kamsteeg@radboudumc.nl</email></corresp>
        <fn>
          <p>MHM and EJK share senior coauthorship.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>2</month>
        <year>2015</year>
      </pub-date>
      <volume>52</volume>
      <issue>5</issue>
      <fpage>330</fpage>
      <lpage>337</lpage>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="rev-recd">
          <day>1</day>
          <month>2</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>2</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:href="jmedgenet-2014-102813.pdf"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Mutations of <italic>SCN8A</italic> encoding the neuronal voltage-gated sodium channel Na<sub>V</sub>1.6 are associated with early-infantile epileptic encephalopathy type 13 (EIEE13) and intellectual disability. Using clinical exome sequencing, we have detected three novel de novo <italic>SCN8A</italic> mutations in patients with intellectual disabilities, and variable clinical features including seizures in two patients. To determine the causality of these <italic>SCN8A</italic> mutations in the disease of those three patients, we aimed to study the (dys)function of the mutant sodium channels.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>The functional consequences of the three <italic>SCN8A</italic> mutations were assessed using electrophysiological analyses in transfected cells. Genotypeâphenotype correlations of these and other cases were related to the functional analyses.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The first mutant displayed a 10âmV hyperpolarising shift in voltage dependence of activation (gain of function), the second did not form functional channels (loss of function), while the third mutation was functionally indistinguishable from the wildtype channel.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Comparison of the clinical features of these patients with those in the literature suggests that gain-of-function mutations are associated with severe EIEE, while heterozygous loss-of-function mutations cause intellectual disability with or without seizures. These data demonstrate that functional analysis of missense mutations detected by clinical exome sequencing, both inherited and de novo, is valuable for clinical interpretation in the age of massive parallel sequencing.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Epilepsy and seizures</kwd>
        <kwd>Movement disorders (other than Parkinsons)</kwd>
        <kwd>intelectual disability</kwd>
        <kwd>sodium channel</kwd>
        <kwd>encephalopathy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>special-feature</meta-name>
          <meta-value>unlocked</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Exome sequencing has revolutionised the detection of disease-causing mutations, both in research and in diagnostic laboratories. The ease of exome-wide sequencing has led to the discovery of unanticipated associations between gene mutations and disease. However, there is a risk of overinterpreting the role of private mutations in a given gene with disease. Thus, a combination of segregation analysis, metabolic testing and/or functional studies is increasingly important to establish the link between isolated mutations and a patient's disorder.</p>
      <p>Nine genes encoding distinct voltage-gated Na<sup>+</sup> channel Î± subunits Na<sub>V</sub>1.1â1.9 have been identified and functionally characterised.<xref rid="R1" ref-type="bibr">1</xref> The gene <italic>SCN8A</italic> encodes the Na<sub>V</sub>1.6 Î± subunit, which is abundantly expressed throughout the central nervous system, including high expression in the cerebellum, hippocampus, cortex and olfactory bulb.<xref rid="R2" ref-type="bibr">2â6</xref> Primary motor neurons as well as cerebellar Purkinje and granule cells have strong expression of Na<sub>V</sub>1.6, suggesting a role in motor control.<xref rid="R2" ref-type="bibr">2</xref>
<xref rid="R3" ref-type="bibr">3</xref>
<xref rid="R7" ref-type="bibr">7</xref> Na<sub>V</sub>1.6 channels are enriched at the neuronal axon initial segment and nodes of Ranvier, where they promote neuronal excitability by participating in the initiation and propagation of action potentials.<xref rid="R8" ref-type="bibr">8â12</xref> Na<sub>V</sub>1.6 channels generate persistent current, hyperpolarised thresholds of activation compared with other Na<sub>V</sub> channels, and resurgent current (reviewed in<xref rid="R13" ref-type="bibr">13</xref>). These biophysical properties make Na<sub>V</sub>1.6 a critical mediator of neuronal excitability.</p>
      <p>Homozygous null mice lacking functional Na<sub>V</sub>1.6 display severe motor deficits<xref rid="R4" ref-type="bibr">4</xref>
<xref rid="R14" ref-type="bibr">14â16</xref> and impaired learning,<xref rid="R17" ref-type="bibr">17</xref> while heterozygous null animals display absence epilepsy,<xref rid="R18" ref-type="bibr">18</xref> disturbed sleep pattern<xref rid="R19" ref-type="bibr">19</xref> and anxiety.<xref rid="R13" ref-type="bibr">13</xref>
<xref rid="R20" ref-type="bibr">20</xref> Pathological-induced or drug-induced increases in Na<sub>V</sub>1.6 activity have been associated with susceptibility to epilepsy.<xref rid="R21" ref-type="bibr">21â23</xref> In humans, an inherited frameshift mutation in <italic>SCN8A</italic> was identified in a child with intellectual disability (ID), ataxia and attention-deficit hyperactivity disorder (ADHD).<xref rid="R24" ref-type="bibr">24</xref> This frameshift mutation was also present in the patient's mother and maternal aunt, who had ID without ataxia, and in a maternal nephew with isolated ADHD. In 2012, the first de novo <italic>SCN8A</italic> missense mutation was described in a child with severe epileptic encephalopathy.<xref rid="R25" ref-type="bibr">25</xref> Recently, &gt;30 de novo mutations in <italic>SCN8A</italic> have been identified in patients suffering from early-infantile epileptic encephalopathy type 13 (EIEE13), characterised by early-onset (refractory) epilepsy, features of autism and ID.<xref rid="R26" ref-type="bibr">26â32</xref> Only three of these mutations have been subjected to functional analysis to determine the consequences for Na<sub>V</sub>1.6 channel activity.<xref rid="R25" ref-type="bibr">25</xref>
<xref rid="R28" ref-type="bibr">28</xref>
<xref rid="R32" ref-type="bibr">32</xref> Two of the tested mutants, p.(Asn1768Asp) and p.(Thr767Ile), induced gain-of-function effects and hyperactivity, suggesting that EIEE13 can be caused by elevated Na<sub>V</sub>1.6 activity.</p>
      <p>Here, using clinical exome sequencing in patients with ID, we identified three novel de novo mutations in <italic>SCN8A</italic>. The patients had ID with additional variable symptoms, including seizures, abnormalities on brain MRI, spasticity and facial dysmorphisms. We carried out electrophysiological analysis to characterise the effects of the identified mutations on the activity of the mutant Na<sub>V</sub>1.6 channels. This analysis demonstrated one mutation with gain-of-function and elevated channel activity, one with apparent loss of function and a third with no detectable functional effects. These results are discussed with respect to the individual clinical phenotypes.</p>
    </sec>
    <sec sec-type="methods" id="s2">
      <title>Methods</title>
      <sec id="s2a">
        <title>Patients and clinical exome sequencing</title>
        <p>The patients were referred to the Department of Human Genetics of the Radboud University Medical Center (Nijmegen, the Netherlands) for genetic diagnostic evaluation of unexplained ID/developmental delay and/or a movement disorder. Clinical exome sequencing was part of the routine diagnostic procedure. Previous genome-wide chromosomal analyses gave normal results. Patients 1 and 3 were assessed through a family-based exome sequencing (âtrioâ-exome sequencing) approach.<xref rid="R33" ref-type="bibr">33</xref>
<xref rid="R34" ref-type="bibr">34</xref> Patient 2, who also had ID, was part of a cohort of approximately 100 patients with movement disorders, predominantly ataxia or spastic paraplegia. Exome sequencing was performed essentially as described previously<xref rid="R35" ref-type="bibr">35</xref> and in online supplementary data.</p>
      </sec>
      <sec id="s2b">
        <title>Cell culture and transfection</title>
        <p>Human embryonic kidney cells (HEK293) were grown at 37Â°C in Dulbecco's modified Eagle's medium (Biowhittaker Europe, Vervier, Belgium) supplemented with 10% (v/v) fetal calf serum (PAA Laboratories, Linz, Austria), non-essential amino acids and 2âmM L-glutamine in a humidified 5% (v/v) CO<sub>2</sub> atmosphere. Cells were seeded in 12-well plates and subsequently transfected with 1.5âÎ¼g of Na<sub>V</sub>1.6 construct and 150âng enhanced green fluorescent protein using Lipofectamine 2000 (Invitrogen). Three mutations were introduced into the tetrodotoxin (TTX)-resistant derivative of the murine Na<sub>V</sub>1.6 cDNA clone Na<sub>V</sub>1.6R as described previously.<xref rid="R25" ref-type="bibr">25</xref>
<xref rid="R28" ref-type="bibr">28</xref>
<xref rid="R32" ref-type="bibr">32</xref> Analysis of human mutations in the context of this TTX-resistant cDNA has facilitated the delineation of biophysical changes produced by human mutations in Na<sub>v</sub>1.6.<xref rid="R25" ref-type="bibr">25</xref>
<xref rid="R28" ref-type="bibr">28</xref> The three substituted amino acids (D58, N984 and G1451) are conserved between human and mouse Na<sub>V</sub>1.6 (<xref ref-type="fig" rid="JMEDGENET2014102813F1">figure 1</xref>). The 6 kb open-reading frame was sequenced to confirm the absence of additional mutations. The day after transfection, cells were seeded on glass coverslips coated with 50âÂµg/mL of fibronectin (Roche, Mannheim, Germany). Approximately 20âh after transfection, cells were placed in the recording chamber and selected for recording based on intensity of fluorescent reporter.</p>
        <fig id="JMEDGENET2014102813F1" orientation="portrait" position="float">
          <label>FigureÂ 1</label>
          <caption>
            <p>Localisation and evolutionary conservation of three newly identified de novo mutations in <italic>SCN8A</italic> encoding the sodium channel Na<sub>V</sub>1.6. (A) The D58 residue in the N-terminus. (B) N984 in the intracellular loop close to the sixth transmembrane helix of domain 2 (D2S6). (C) G1451 in the sixth transmembrane helix of domain 3 (DIIIS6), in close proximity to the channel pore. h, <italic>Homo sapiens</italic>; m, <italic>Mus musculus</italic>; a, <italic>Anolis carolinensis</italic> (reptile); f, <italic>Takifugu rubripes</italic> (fish); dpara, <italic>Drosophila melanogaster</italic> âparalyticâ (alternative name Na<sub>V</sub>1). Amino acids are indicated by the single-letter code and dots represent identity to the human amino acid. Multiple sequence alignment was carried out using ClustalW V.2.0.12.<xref rid="R48" ref-type="bibr">48</xref></p>
          </caption>
          <graphic xlink:href="jmedgenet-2014-102813f01"/>
        </fig>
      </sec>
      <sec id="s2c">
        <title>Electrophysiology</title>
        <p>Measurements were carried out at the Department of Physiology (Radboud University Medical Center, the Netherlands) with an EPC9 patch clamp amplifier and Patchmaster software (HEKA electronics, Lambrecht, Germany). The sampling interval was set at 50âÂµs (20âkHz) and low-pass filtering was set to 5.0âkHz in all experiments. Pipettes were pulled from thin-wall borosilicate glass and had resistances between 0.9 and 1.5âMÎ© when filled with the pipette solution. Series resistance compensation was set to 85â95% in all experiments. The leak currents were subtracted using a P/6 procedure from a holding potential of â120âmV.</p>
        <p>Currents were activated by 40âms voltage pulses ranging from â70 to +20âmV (in 10âmV increments) from a holding potential of â120âmV at a sweep frequency of 0.2âHz. Currentâvoltage curves were converted to conductanceâvoltage curve, normalised and individually fitted with a Boltzmann equation (see below). Steady-state inactivation was studied by holding cells at conditioning voltage ranging from â120 to â20âmV (in 10âmV increments) for 500âms and tested with a 40âms depolarising pulse to â10âmV. The current elicited after the conditioning voltage period was normalised to the current amplitude obtained from a holding voltage of â120âmV obtained before the conditioning period.</p>
        <p>The extracellular solution contained (in mM): 132 NaCl, 4.2 KCl, 1 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 hydroxyethyl piperazineethanesulfonic acid (HEPES), 25 glucose and pH adjusted to 7.4 with NaOH. The pipette solution contained (in mM): 140 CsF, 10 NaCl, 1 ethylene glycol tetraacetic acid, 10 HEPES and pH adjusted to 7.3 using CsOH. After break-in, a 5âmin waiting period permitted equilibration between the pipette solution and the cytoplasm of the cell. Current density was calculated by dividing the current (in pA) by the cell capacitance (in pF).</p>
      </sec>
      <sec id="s2d">
        <title>Statistical analysis and fitting of electrophysiological data</title>
        <p>Currentâvoltage curves were converted to conductance and fitted using the following Boltzmann equation: g(V)=g<sub>max</sub>/(1+exp((VâV<sub>0.5</sub>)/k)), where g is the conductance, g<sub>max</sub> is the maximal conductance, V is the voltage, V<sub>0.5</sub> is the voltage of half-maximal activation and k is the slope factor. Steady-state inactivation curves were fitted with an analogous equation. Data are shown as meanÂ±SEM. The comparisons between mean of the fit parameters and amplitudes were performed using one-way analysis of variance followed by Tukey post hoc test.</p>
      </sec>
      <sec id="s2e">
        <title>Western blotting</title>
        <p>To assess protein stability, mutant cDNAs were transfected into HEK293 cells, which lack endogenous sodium channel protein. After culture for 24âh at 37Â°C, transfected cells were harvested and lysed in radioimmunoprecipitation assay buffer. Aliquots containing 30âÎ¼g of protein were incubated with Laemmli sample buffer for 20âmin at 37Â°C, electrophoresed through 4â15% acrylamide gradient gels (Criterion) and immunostained with rabbit polyclonal anti-Nav1.6 (Alomone ASC-009, 1:100). As an internal control, Î±-tubulin was immunostained with a 1:1000 dilution of monoclonal antibody CLT9002 (Cedarlane Labs, Burlington, Canada).</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Clinical phenotypes</title>
        <p>In total, 500 patients with ID and 100 patients with a movement disorder were subjected to exome sequencing. Three patients carried mutations of <italic>SCN8A.</italic> One of them was included in the movement disorders group also, despite having an ID, because of his pronounced movement disorder. The clinical features of these patients are summarised in <xref rid="JMEDGENET2014102813TB1" ref-type="table">table 1</xref> and in online supplementary data. Patients 1 and 2 experienced seizures and peripheral nervous system disabilities, but these were not present in patient 3.</p>
        <table-wrap id="JMEDGENET2014102813TB1" orientation="portrait" position="float">
          <label>TableÂ 1</label>
          <caption>
            <p>Clinical features of three patients with de novo mutations in <italic>SCN8A</italic></p>
          </caption>
          <table frame="hsides" rules="groups">
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="left" span="1"/>
              <col align="left" span="1"/>
              <col align="left" span="1"/>
            </colgroup>
            <thead valign="bottom">
              <tr>
                <th align="left" rowspan="1" colspan="1">Patient</th>
                <th align="left" rowspan="1" colspan="1">1</th>
                <th align="left" rowspan="1" colspan="1">2</th>
                <th align="left" rowspan="1" colspan="1">3</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">Sex and age</td>
                <td rowspan="1" colspan="1">Female, 7âyears</td>
                <td rowspan="1" colspan="1">Male, 33âyears</td>
                <td rowspan="1" colspan="1">Male, 33âyears</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">OFC (centile)</td>
                <td rowspan="1" colspan="1">51.5âcm (&gt;P50)</td>
                <td rowspan="1" colspan="1">55.2âcm (P5âP10)</td>
                <td rowspan="1" colspan="1">55,8âcm (P10)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Seizures</td>
                <td rowspan="1" colspan="1">Frequent, intractable seizures with an onset at the age of 6âweeks</td>
                <td rowspan="1" colspan="1">First seizures at age 18âmonths, including absences and tonicâclonic seizures</td>
                <td rowspan="1" colspan="1">None</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">DD/ID</td>
                <td rowspan="1" colspan="1">Severe DD since birth
Not able to sit independently
No speech</td>
                <td rowspan="1" colspan="1">Moderate to severe DD<break/>Walking at age 6âyears<break/>First words at age 6âyears<break/>Developmental level at adult age comparable to a 4â5âyears old</td>
                <td rowspan="1" colspan="1">DD since birth<break/>Walking after 18âmonths<break/>Relatively normal speech, but cannot write or read<break/>Adult IQ of 55</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Neurological symptoms</td>
                <td rowspan="1" colspan="1">Neonatal hypertonia<break/>Severe dysregulation of muscle tone<break/>Neurogenic bladder due to tethered cord</td>
                <td rowspan="1" colspan="1">Nystagmus<break/>Jerky pursuit<break/>Spastic tetraplegia</td>
                <td rowspan="1" colspan="1">None</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Brain MRI</td>
                <td rowspan="1" colspan="1">Progressive cerebral atrophy</td>
                <td rowspan="1" colspan="1">Cerebellar atrophy</td>
                <td rowspan="1" colspan="1">Cerebral atrophy</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Dysmorphisms</td>
                <td rowspan="1" colspan="1">Tapering fingers<break/>Mild facial dysmorphisms, including synophrys, broad nasal tip and upslanted palpebral fissures</td>
                <td rowspan="1" colspan="1">None</td>
                <td rowspan="1" colspan="1">Ptosis, asymmetric skull, broad forehead, high palate with narrow uvula, small jaw<break/>Clinodactyly second fingers<break/>Pectus excavatum</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Miscellaneous<break/>(non)-neurological</td>
                <td rowspan="1" colspan="1">Precocious puberty<break/>(6âyears)<break/>Convex scoliosis<break/>Severe feeding difficulties<break/>Unexplained spontaneous fractures</td>
                <td rowspan="1" colspan="1">Decline in motor, and to a lesser extent in cognitive functioning since the age of 29 years
Recurrent falls
Swallowing difficulties</td>
                <td rowspan="1" colspan="1">Inguinal and umbilical hernia
Behaviour problems
Mild hypothyroidism</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Mutations (de novo)</td>
                <td rowspan="1" colspan="1"><italic>SCN8A:</italic><break/>c.2952C&gt;G<break/>p.(Asn984Lys) near D2S6</td>
                <td rowspan="1" colspan="1"><italic>SCN8A</italic>:<break/>c.4351G&gt;A<break/>p.(Gly1451Ser) in D3S6</td>
                <td rowspan="1" colspan="1">SCN8A: c.172G&gt;A p.(Asp58Asn) in Nterm RING1: c.284G&gt;A; p.(Arg95Gln)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Reference sequences SCN8A: NM_014191.2 and RING1: NM_002931.3. Mutation nomenclature is according to the Human Genome Variation Society guidelines.</p>
            </fn>
            <fn>
              <p>DD, developmental delay; ID, intellectual disability; OCF, occipitofrontal circumference.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s3b">
        <title>Mutation detection</title>
        <p>In patient 1, a single de novo mutation was revealed after trio-exome sequencing, <italic>SCN8A</italic> (c.2952C&gt;G; p.(Asn984Lys)). This mutation alters an evolutionarily conserved amino acid adjacent to the transmembrane segment of the voltage-gated sodium channel Nav1.6 (N984K; <xref ref-type="fig" rid="JMEDGENET2014102813F1">figure 1</xref>). Singleton sequencing of patient 2 and analysis for mutations in a movement disorder gene panel (including genes for ataxia, spastic paraplegia and dystonia) did not identify pathogenic variants. After inspection of the full exome data, an <italic>SCN8A</italic> mutation was identified as a candidate (c.4351G&gt;A; p.(Gly1451Ser)). The mutated residue is located in a conserved residue of transmembrane segment D3S6 of Nav1.6 (G1451S; <xref ref-type="fig" rid="JMEDGENET2014102813F1">figure 1</xref>). Sanger sequencing of parental DNA revealed that this mutation had also occurred de novo. In patient 3, two de novo mutations were identified by trio-exome sequencing, <italic>SCN8A</italic> (c.172G&gt;A; p.(Asp58Asn)) and <italic>RING 1</italic> (c.284G&gt;A; p.(Arg95Gln)). This <italic>SCN8A</italic> mutation alters a residue in the cytoplasmic N-terminus (D58N; <xref ref-type="fig" rid="JMEDGENET2014102813F1">figure 1</xref>). No likely causative homozygous or compound heterozygous mutations were detected in the exome data of these three patients. Hemizygous mutations were also excluded for patients 2 and 3.</p>
      </sec>
      <sec id="s3c">
        <title>Electrophysiological characterisation of Na<sub>V</sub>1.6 Î± subunit mutants</title>
        <p>HEK293 cells were transfected with wildtype (wt) or mutated <italic>SCN8A</italic> cDNA encoding the Na<sub>V</sub>1.6 Î± subunit and subjected to whole-cell patch clamp measurements essentially as described previously.<xref rid="R36" ref-type="bibr">36</xref> Cells expressing wt Na<sub>V</sub>1.6, N984K or D58N demonstrated substantial voltage-evoked currents (<xref ref-type="fig" rid="JMEDGENET2014102813F2">figure 2</xref>A). Although current amplitudes did not reach their maximal value at the same test voltage, the average maximal inward currents observed for the wt channel and for the D58N and N984K mutants were not statistically different from each other (<xref ref-type="fig" rid="JMEDGENET2014102813F2">figure 2</xref>B). Current densities in cells expressing the G1451S mutant were â¼10-fold smaller than wt transfected cells and were comparable to non-transfected cells (<xref ref-type="fig" rid="JMEDGENET2014102813F2">figure 2</xref>A). To determine whether the loss of activity of the G1451S was a consequence of protein instability, as recently reported for the R223G mutation,<xref rid="R32" ref-type="bibr">32</xref> we carried out western blotting. The G1451S mutant proteins were detected in similar levels as wt Na<sub>V</sub>1.6 in transfected cells (see online supplementary figure S3).</p>
        <fig id="JMEDGENET2014102813F2" orientation="portrait" position="float">
          <label>FigureÂ 2</label>
          <caption>
            <p>Voltage-evoked currents of mutant proteins in transfected HEK293 cells. (A) Wild type (wt), D58N and N984K gave rise to substantial voltage-evoked currents while the G1451S expressing cells demonstrated current densities similar to non-transfected cells. (B) Average currentâvoltage curve for non-transfected cells (squares), wt (full circles), D58N (upward triangles), N984K (downward triangles) and G1451S (stars). N=3 for non-transfected cells, and Nâ¥10 for all other conditions.</p>
          </caption>
          <graphic xlink:href="jmedgenet-2014-102813f02"/>
        </fig>
        <p>Wt and D58N mutant channels generated currents with similar voltage of half-maximal activation (V<sub>0.5</sub>, <xref ref-type="fig" rid="JMEDGENET2014102813F3">figure 3</xref>B, see 'Methodsâ section). Strikingly, the N984K mutant had a 10âmV hyperpolarising shift in V<sub>0.5</sub> in comparison with wt (<xref ref-type="fig" rid="JMEDGENET2014102813F3">figure 3</xref>B). The slope factor k of the Boltzmann fit was not different between conditions (p&gt;0.05, nâ¥10). Cells were subjected to a steady-state inactivation protocol in order to study fast inactivation (<xref ref-type="fig" rid="JMEDGENET2014102813F3">figure 3</xref>C and see <italic>â</italic>Methodsâ section). Currents from cells expressing wt, N984K and D58N demonstrated no statistically significant differences in voltage dependence of steady-state inactivation or slope (<xref ref-type="fig" rid="JMEDGENET2014102813F3">figure 3</xref>D).</p>
        <fig id="JMEDGENET2014102813F3" orientation="portrait" position="float">
          <label>FigureÂ 3</label>
          <caption>
            <p>Voltage dependence of activation and steady-state inactivation of mutant proteins in transfected HEK293 cells. (A) Individual currentâvoltage (IâV) curves were converted to normalised conductanceâvoltage (g-V) curves and fitted with a Boltzmann equation yielding the voltage of half-maximal activation (V<sub>0.5</sub>) and slope factor (k). (B) Average normalised conductances of wild type (wt), D58N and N984K as a function of voltage. Lines represent Boltzmann fit to the average conductance voltage curve. The N984K mutant V<sub>0.5</sub> is significantly shifted towards hyperpolarised voltages values (p&lt;0.05, n=10). Nâ¥10 for each conditions. (C) The protocol used to study steady-state inactivation is shown. The fraction of non-inactivated channels after a 500âms conditioning period is indicated as the ratio of the current after the conditioning period (I<sub>2</sub>) to the current obtained before conditioning (I<sub>1</sub>). (D) The average current ratio (I<sub>2</sub>/I<sub>1</sub>) for wt, D58N and N984K as a function of the conditioning voltage. The dotted line represents a modified Boltzmann fit to the average wt steady-state inactivation curve. Fit to D58N and N984 is not shown for the purpose of clarity. There is no difference in voltage of half-maximal inactivation between wt and mutants (p&gt;0.05, nâ¥8).</p>
          </caption>
          <graphic xlink:href="jmedgenet-2014-102813f03"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>We report three novel de novo missense mutations in <italic>SCN8A</italic> identified by clinical exome sequencing in patients with ID and variable clinical features. The degree of developmental delay varied from profound ID in patient 1 to moderate ID in patients 2 and 3. Patients 1 and 2 also presented with epilepsy and a movement disorder (including hypertonia, spasticity and ataxia), whereas patient 3 had no such signs. Comparison of the electrophysiological properties of the mutant channels revealed distinct effects.</p>
      <p>Patient 1 is most severely affected clinically, with a diagnosis of EIEE that included onset of intractable seizures at 6âweeks of age, feeding by gastric tube and lack of speech. The N984K mutation of <italic>SCN8A</italic> in this patient resulted in a hyperpolarising shift of â¼10âmV in the voltage dependence of activation (<xref ref-type="fig" rid="JMEDGENET2014102813F2">figures 2</xref> and <xref ref-type="fig" rid="JMEDGENET2014102813F3">3</xref>), which predicts premature channel opening and hyperactivity of neurons. A similar hyperpolarising shift in voltage dependence of activation of <italic>SCN8A</italic> was recently reported in a severely affected child with the de novo mutation T767I in transmembrane segment D2S1, seizure onset at 2âweeks of age, profound developmental delay and feeding by gastric tube.<xref rid="R28" ref-type="bibr">28</xref> These two cases, together with the original N1768D mutation,<xref rid="R25" ref-type="bibr">25</xref> demonstrate clearly that gain-of-function mutations of <italic>SCN8A</italic> that cause elevated channel activity result in severe EIEE.</p>
      <p>In patient 2, the G1451S mutation causes apparent loss of channel activity in the HEK cell assay. G1451 is located in a residue of domain 3 that has been suggested to regulate bending of the pore-lining S6 segment during the opening of the channel pore<xref rid="R37" ref-type="bibr">37</xref> and would be expected to alter channel activity. Patient 2 had later seizure onset, at 18âmonths of age, and severe developmental delay, but could walk and speak at 6âyears of age. In a similar case, the partial loss-of-function mutation R223G was described in a patient with seizure onset at 6âmonths and profound developmental impairment.<xref rid="R32" ref-type="bibr">32</xref> Both of these missense mutations generate full-length protein with reduced channel activity and have a severe clinical phenotype including early-onset seizures. Both patients are more severely affected than the family with an SCN8A protein truncation mutation, which resulted in ID without seizures.<xref rid="R24" ref-type="bibr">24</xref> Two protein truncation mutations have been described in the ESP6500 dataset, but one is an indel of one C nucleotide in a run of four Cs, and the second is a singleton; neither has been confirmed by Sanger sequencing and both must be considered unconfirmed. In three other patients with ID without seizures, loss of <italic>SCN8A</italic> protein due to contiguous gene deletion has been described; at least two were de novo deletions (<ext-link ext-link-type="uri" xlink:href="http://decipher.sanger.ac.uk">http://decipher.sanger.ac.uk</ext-link>). The difference between the protein truncation or deletion patients, and the missense patients, suggests that there may be a dominant effect of the full-length inactive proteins with the G1451S and R223G mutations. The mutant proteins could result in sequestration of interacting proteins such as Î² subunits, which is required for neurite outgrowth and high-frequency neuronal firing of Na<sub>V</sub>1.6 expressing neurons.<xref rid="R38" ref-type="bibr">38</xref> Alternatively, there may be gain-of-function features of these proteins that were not detected in the heterologous HEK293 cell assay. Such an observation was made with a mutation of Na<sub>V</sub>1.1, with apparent loss of function in cultured non-neuronal cells, which was partially rescued in primary cultures of mouse embryo neocortical neurons and exhibited a gain-of-function effect.<xref rid="R39" ref-type="bibr">39</xref> The subcellular localisation of the G1451S mutant of Na<sub>V</sub>1.6 has not yet been established, and it will be important to examine this mutant in a neuronal cell assay.</p>
      <p>The third patient carried the de novo mutation D58N located in the cytoplasmic N-terminal domain of the protein. Electrophysiological analysis revealed full activity of this mutant channel in HEK cells, with no change in biophysical properties. The N-terminal domain of Nav1.6 is likely to function in protein trafficking rather than channel activity. The mutation S21P in the N-terminus of mouse Nav1.6 results in protein retention in the endoplasmic reticulum.<xref rid="R40" ref-type="bibr">40</xref> A binding site for the microtubule-associated protein MAP1B has been mapped between residues 77 and 88 of Nav1.6.<xref rid="R41" ref-type="bibr">41</xref> The activity of the D58N mutant channel in HEK cells demonstrates successful transport to the cell surface, suggesting that this mutation is not pathogenic. However, it is possible that localisation of the D58N channel to the axon initial segment or node of Ranvier in neurons could be impaired. Nevertheless, with the apparent normal function of the D58N mutants in HEK cells, it is also possible that ID in patient 3 might be caused by the second de novo mutation in the <italic>RING1</italic> gene encoding a E3 ubiquitin ligase<italic>.</italic> Mutations in <italic>RING1</italic> have not been previously associated with ID. The future detection of similar <italic>SCN8A</italic> or <italic>RING1</italic> mutations may resolve this issue.</p>
      <p>Despite the fact that only six <italic>SCN8A</italic> mutations have been tested functionally, preliminary correlations between mutation type and disease severity are emerging (<xref rid="JMEDGENET2014102813TB2" ref-type="table">table 2</xref>). First, the de novo <italic>SCN8A</italic> mutations in patients with EIEE13, the most severe form of <italic>SCN8A</italic>-related disease, are missense mutations rather than protein truncation mutations.<xref rid="R13" ref-type="bibr">13</xref> Second, three of these missense mutations clearly result in channel hyperactivity, leading to both seizures and ID. Third, complete loss of function due to protein truncation or gene deletion is associated with isolated ID without seizures<xref rid="R24" ref-type="bibr">24</xref> (<ext-link ext-link-type="uri" xlink:href="http://decipher.sanger.ac.uk">http://decipher.sanger.ac.uk</ext-link>). In the heterologous test systems used for analysis, two missense mutations associated with ID and epilepsy, G1451S and R223G, exhibit (partial) loss-of-function rather than hyperactivity; these merit additional study to detect possible gain-of-function features.</p>
      <table-wrap id="JMEDGENET2014102813TB2" orientation="portrait" position="float">
        <label>TableÂ 2</label>
        <caption>
          <p>Functional analysis of <italic>SCN8A</italic> mutations identified in heterozygous state in patients with intellectual disability (ID) with or without epileptic encephalopathy (EE)</p>
        </caption>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
            <col align="left" span="1"/>
          </colgroup>
          <thead valign="bottom">
            <tr>
              <th align="left" rowspan="1" colspan="1">Protein change</th>
              <th align="left" rowspan="1" colspan="1">ID</th>
              <th align="left" rowspan="1" colspan="1">EE</th>
              <th align="left" rowspan="1" colspan="1">Cell assay</th>
              <th align="left" rowspan="1" colspan="1">Effect on function</th>
              <th align="left" rowspan="1" colspan="1">Ref.</th>
              <th align="left" rowspan="1" colspan="1">Channel domain</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">N1768D</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">Neuronal</td>
              <td rowspan="1" colspan="1">GOF, increased persistent current</td>
              <td rowspan="1" colspan="1">
                <xref rid="R25" ref-type="bibr">25</xref>
              </td>
              <td rowspan="1" colspan="1">In D4S6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">T1716I</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">NeuronalÂ </td>
              <td rowspan="1" colspan="1">GOF, hyperpolarizing shift in activation voltage</td>
              <td rowspan="1" colspan="1">
                <xref rid="R28" ref-type="bibr">28</xref>
              </td>
              <td rowspan="1" colspan="1">In D2S1</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">N984K</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">HEK</td>
              <td rowspan="1" colspan="1">GOF, hyperpolarizing shift in activation voltage</td>
              <td rowspan="1" colspan="1">This article</td>
              <td rowspan="1" colspan="1">Near D2S6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">G1451S</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">HEK</td>
              <td rowspan="1" colspan="1">LOF at 37Â°C</td>
              <td rowspan="1" colspan="1">This article</td>
              <td rowspan="1" colspan="1">in D3S6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">R223G</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">HEK</td>
              <td rowspan="1" colspan="1">Partial LOF; thermolabile.<break/>Protein is unstable at 37Â°C, active at 30Â°C</td>
              <td rowspan="1" colspan="1">
                <xref rid="R32" ref-type="bibr">32</xref>
              </td>
              <td rowspan="1" colspan="1">In D1S4</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">P1719Rfs*6</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">â</td>
              <td rowspan="1" colspan="1">None</td>
              <td rowspan="1" colspan="1">LOF, protein truncation</td>
              <td rowspan="1" colspan="1">
                <xref rid="R24" ref-type="bibr">24</xref>
              </td>
              <td rowspan="1" colspan="1">In D4S5-S6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">D58N</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">â</td>
              <td rowspan="1" colspan="1">HEK</td>
              <td rowspan="1" colspan="1">Wildtype activity; may be non-pathogenic in view of additional de novo mutation</td>
              <td rowspan="1" colspan="1">This article</td>
              <td rowspan="1" colspan="1">In N-termÂ </td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn>
            <p>Missense mutations were introduced into the mouse Na<sub>V</sub>1.6 cDNA and cells were transfected for electrophysiological assays. Only the deduced protein changes (one-letter code) are provided.</p>
          </fn>
          <fn>
            <p>GOF, gain of function; LOF, loss of function.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The data for <italic>SCN8A</italic> are in striking contrast with Dravet syndrome, or EIEE6, which is caused by mutations of the sodium channel <italic>SCN1A</italic>. In Dravet, 50% of the &gt;800 de novo mutations in sodium channel <italic>SCN1A</italic> are protein truncation mutations with clear loss of function, and these result in both seizures and ID.<xref rid="R42" ref-type="bibr">42â44</xref> The milder generalised epilepsy with febrile seizures plus phenotype is associated with missense mutations of <italic>SCN1A</italic>. The difference in the consequences of loss of function may reflect their different roles in inhibitory and excitatory neurons since Na<sub>V</sub>1.6 (encoded by <italic>SCN8A</italic>) is the major sodium channel in excitatory neurons while Na<sub>V</sub>1.1 (encoded by <italic>SCN1A</italic>) appears to have a critical role in inhibitory neurons.<xref rid="R45" ref-type="bibr">45â47</xref></p>
      <p>In summary, we have identified and characterised three novel de novo mutations of <italic>SCN8A</italic>. Electrophysiological studies indicate that one mutation leads to a gain of function (N984K), the second causes apparent loss of function (G1451S) and the third has normal channel activity and may be non-pathogenic (D58N). These data strengthen previous findings linking gain-of-function mutations of <italic>SCN8A</italic> with EIEE and demonstrate the importance of functional testing in establishing the pathogenicity of de novo mutations. Functional characterisation of additional <italic>SCN8A</italic> mutations will provide a more comprehensive understanding of the specific phenotypes associated with gain-of-function and loss-of-function mutations.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <caption>
          <title>Web supplement</title>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="jmedgenet-2014-102813-s1.pdf" orientation="portrait" id="d35e1272" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD2">
        <caption>
          <title>Web supplement</title>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="jmedgenet-2014-102813-s2.pdf" orientation="portrait" id="d35e1277" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD3">
        <caption>
          <title>Web figures</title>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="jmedgenet-2014-102813-s3.pdf" orientation="portrait" id="d35e1282" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Janelle O'Brien and Jacy Wagnon for helpful discussions and assistance.</p>
    </ack>
    <fn-group>
      <fn>
        <p><bold>Contributors:</bold> MGB has contributed to the acquisition, analysis and interpretation of data, and drafting of the manuscript. MHW, JBW, BPvdW, PP, MCJ and JN contributed to data acquisition, interpretation and revising the manuscript for intellectual content. SD-H, SGW, TK, HGY and RJMB contributed to data interpretation and revising the manuscript for intellectual content. MHM and E-JK are accountable for design of the work, interpretation of data and revision for intellectual content. All coauthors have approved the final version of the manuscript. No other persons contributed in a way that they are entitled to be coauthors.</p>
      </fn>
      <fn>
        <p><bold>Funding:</bold> Supported by the National Institutes of Health (R01 NS34509 to MHM). SDH and SGW were supported by grants from the Rehabilitation Research Service, the Veterans Administration, USA.</p>
      </fn>
      <fn>
        <p><bold>Competing interests:</bold> None.</p>
      </fn>
      <fn>
        <p><bold>Patient consent:</bold> Obtained.</p>
      </fn>
      <fn>
        <p><bold>Ethics approval:</bold> Ethics committee of the Radboud University Medical Center.</p>
      </fn>
      <fn>
        <p><bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.</p>
      </fn>
      <fn>
        <p><bold>Data sharing statement:</bold> Except for the raw data, no additional data are available. Raw data may be made available if it does not infringe patients rights.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name>, <name><surname>Goldin</surname><given-names>AL</given-names></name>, <name><surname>Waxman</surname><given-names>SG</given-names></name></person-group>
<article-title>International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels</article-title>. <source>Pharmacol Rev</source>
<year>2005</year>;<volume>57</volume>:<fpage>397</fpage>â<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1124/pr.57.4.4</pub-id><pub-id pub-id-type="pmid">16382098</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaller</surname><given-names>KL</given-names></name>, <name><surname>Krzemien</surname><given-names>DM</given-names></name>, <name><surname>Yarowsky</surname><given-names>PJ</given-names></name>, <name><surname>Krueger</surname><given-names>BK</given-names></name>, <name><surname>Caldwell</surname><given-names>JH</given-names></name></person-group>
<article-title>A novel, abundant sodium channel expressed in neurons and glia</article-title>. <source>J Neurosci</source>
<year>1995</year>;
<volume>15</volume><issue>(5 Pt 1)</issue>:<fpage>3231</fpage>â<lpage>42</lpage>.<pub-id pub-id-type="pmid">7751906</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaller</surname><given-names>KL</given-names></name>, <name><surname>Caldwell</surname><given-names>JH</given-names></name></person-group>
<article-title>Developmental and regional expression of sodium channel isoform NaCh6 in the rat central nervous system</article-title>. <source>J Comp Neurol</source>
<year>2000</year>;<volume>420</volume>:<fpage>84</fpage>â<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(20000424)420:1&lt;84::AID-CNE6&gt;3.0.CO;2-9</pub-id><pub-id pub-id-type="pmid">10745221</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgess</surname><given-names>DL</given-names></name>, <name><surname>Kohrman</surname><given-names>DC</given-names></name>, <name><surname>Galt</surname><given-names>J</given-names></name>, <name><surname>Plummer</surname><given-names>NW</given-names></name>, <name><surname>Jones</surname><given-names>JM</given-names></name>, <name><surname>Spear</surname><given-names>B</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<article-title>Mutation of a new sodium channel gene, Scn8a, in the mouse mutant âmotor endplate disease</article-title>â. <source>Nat Genet</source>
<year>1995</year>;<volume>10</volume>:<fpage>461</fpage>â<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/ng0895-461</pub-id><pub-id pub-id-type="pmid">7670495</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>W</given-names></name>, <name><surname>Tian</surname><given-names>C</given-names></name>, <name><surname>Li</surname><given-names>T</given-names></name>, <name><surname>Yang</surname><given-names>M</given-names></name>, <name><surname>Hou</surname><given-names>H</given-names></name>, <name><surname>Shu</surname><given-names>Y</given-names></name></person-group>
<article-title>Distinct contributions of Na(v)1.6 and Na(v)1.2 in action potential initiation and backpropagation</article-title>. <source>Nat Neurosci</source>
<year>2009</year>;<volume>12</volume>:<fpage>996</fpage>â<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2359</pub-id><pub-id pub-id-type="pmid">19633666</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>JP</given-names></name>, <name><surname>Khera</surname><given-names>DS</given-names></name>, <name><surname>Nersesyan</surname><given-names>H</given-names></name>, <name><surname>Kimchi</surname><given-names>EY</given-names></name>, <name><surname>Waxman</surname><given-names>SG</given-names></name>, <name><surname>Blumenfeld</surname><given-names>H</given-names></name></person-group>
<article-title>Dysregulation of sodium channel expression in cortical neurons in a rodent model of absence epilepsy</article-title>. <source>Brain Res</source>
<year>2004</year>;<volume>1000</volume>:<fpage>102</fpage>â<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2003.11.051</pub-id><pub-id pub-id-type="pmid">15053958</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaller</surname><given-names>KL</given-names></name>, <name><surname>Caldwell</surname><given-names>JH</given-names></name></person-group>
<article-title>Expression and distribution of voltage-gated sodium channels in the cerebellum</article-title>. <source>Cerebellum</source>
<year>2003</year>;<volume>2</volume>:<fpage>2</fpage>â<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1080/14734220309424</pub-id><pub-id pub-id-type="pmid">12882229</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasser</surname><given-names>A</given-names></name>, <name><surname>Ho</surname><given-names>TS</given-names></name>, <name><surname>Cheng</surname><given-names>X</given-names></name>, <name><surname>Chang</surname><given-names>KJ</given-names></name>, <name><surname>Waxman</surname><given-names>SG</given-names></name>, <name><surname>Rasband</surname><given-names>MN</given-names></name>, <name><surname>Dib-Hajj</surname><given-names>SD</given-names></name></person-group>
<article-title>An ankyrinG-binding motif is necessary and sufficient for targeting Nav1.6 sodium channels to axon initial segments and nodes of Ranvier</article-title>. <source>J Neurosci</source>
<year>2012</year>;<volume>32</volume>:<fpage>7232</fpage>â<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5434-11.2012</pub-id><pub-id pub-id-type="pmid">22623668</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osorio</surname><given-names>N</given-names></name>, <name><surname>Alcaraz</surname><given-names>G</given-names></name>, <name><surname>Padilla</surname><given-names>F</given-names></name>, <name><surname>Couraud</surname><given-names>F</given-names></name>, <name><surname>Delmas</surname><given-names>P</given-names></name>, <name><surname>Crest</surname><given-names>M</given-names></name></person-group>
<article-title>Differential targeting and functional specialization of sodium channels in cultured cerebellar granule cells</article-title>. <source>J Physiol</source>
<year>2005</year>;<volume>569</volume><issue>(Pt 3)</issue>:<fpage>801</fpage>â<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2005.097022</pub-id><pub-id pub-id-type="pmid">16210352</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Wart</surname><given-names>A</given-names></name>, <name><surname>Trimmer</surname><given-names>JS</given-names></name>, <name><surname>Matthews</surname><given-names>G</given-names></name></person-group>
<article-title>Polarized distribution of ion channels within microdomains of the axon initial segment</article-title>. <source>J Comp Neurol</source>
<year>2007</year>;<volume>500</volume>:<fpage>339</fpage>â<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1002/cne.21173</pub-id><pub-id pub-id-type="pmid">17111377</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duflocq</surname><given-names>A</given-names></name>, <name><surname>Le Bras</surname><given-names>B</given-names></name>, <name><surname>Bullier</surname><given-names>E</given-names></name>, <name><surname>Couraud</surname><given-names>F</given-names></name>, <name><surname>Davenne</surname><given-names>M</given-names></name></person-group>
<article-title>Nav1.1 is predominantly expressed in nodes of Ranvier and axon initial segments</article-title>. <source>Mol Cell Neurosci</source>
<year>2008</year>;<volume>39</volume>:<fpage>180</fpage>â<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2008.06.008</pub-id><pub-id pub-id-type="pmid">18621130</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osorio</surname><given-names>N</given-names></name>, <name><surname>Cathala</surname><given-names>L</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name>, <name><surname>Crest</surname><given-names>M</given-names></name>, <name><surname>Magistretti</surname><given-names>J</given-names></name>, <name><surname>Delmas</surname><given-names>P</given-names></name></person-group>
<article-title>Persistent Nav1.6 current at axon initial segments tunes spike timing of cerebellar granule cells</article-title>. <source>J Physiol</source>
<year>2010</year>;<volume>588</volume><issue>(Pt 4)</issue>:<fpage>651</fpage>â<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2010.183798</pub-id><pub-id pub-id-type="pmid">20173079</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>JE</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<article-title>Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability</article-title>. <source>Front Genet</source>
<year>2013</year>;<volume>4</volume>:<fpage>213</fpage>
<pub-id pub-id-type="doi">10.3389/fgene.2013.00213</pub-id><pub-id pub-id-type="pmid">24194747</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohrman</surname><given-names>DC</given-names></name>, <name><surname>Plummer</surname><given-names>NW</given-names></name>, <name><surname>Schuster</surname><given-names>T</given-names></name>, <name><surname>Jones</surname><given-names>JM</given-names></name>, <name><surname>Jang</surname><given-names>W</given-names></name>, <name><surname>Burgess</surname><given-names>DL</given-names></name>, <name><surname>Galt</surname><given-names>J</given-names></name>, <name><surname>Spear</surname><given-names>BT</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<article-title>Insertional mutation of the motor endplate disease (med) locus on mouse chromosome 15</article-title>. <source>Genomics</source>
<year>1995</year>;<volume>26</volume>:<fpage>171</fpage>â<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/0888-7543(95)80198-U</pub-id><pub-id pub-id-type="pmid">7601440</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>SI</given-names></name>, <name><surname>Khaliq</surname><given-names>ZM</given-names></name>, <name><surname>Aman</surname><given-names>TK</given-names></name>, <name><surname>Grieco</surname><given-names>TM</given-names></name>, <name><surname>Kearney</surname><given-names>JA</given-names></name>, <name><surname>Raman</surname><given-names>IM</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<article-title>Impaired motor function in mice with cell-specific knockout of sodium channel Scn8a (NaV1.6) in cerebellar purkinje neurons and granule cells</article-title>. <source>J Neurophysiol</source>
<year>2006</year>;<volume>96</volume>:<fpage>785</fpage>â<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1152/jn.01193.2005</pub-id><pub-id pub-id-type="pmid">16687615</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>M</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name>, <name><surname>Richter</surname><given-names>A</given-names></name></person-group>
<article-title>Motor disturbances in mice with deficiency of the sodium channel gene Scn8a show features of human dystonia</article-title>. <source>Exp Neurol</source>
<year>2003</year>;<volume>184</volume>:<fpage>830</fpage>â<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-4886(03)00290-5</pub-id><pub-id pub-id-type="pmid">14769375</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodruff-Pak</surname><given-names>DS</given-names></name>, <name><surname>Green</surname><given-names>JT</given-names></name>, <name><surname>Levin</surname><given-names>SI</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<article-title>Inactivation of sodium channel Scn8A (Na-sub(v)1.6) in Purkinje neurons impairs learning in Morris water maze and delay but not trace eyeblink classical conditioning</article-title>. <source>Behav Neurosci</source>
<year>2006</year>;<volume>120</volume>:<fpage>229</fpage>â<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1037/0735-7044.120.2.229</pub-id><pub-id pub-id-type="pmid">16719687</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papale</surname><given-names>LA</given-names></name>, <name><surname>Beyer</surname><given-names>B</given-names></name>, <name><surname>Jones</surname><given-names>JM</given-names></name>, <name><surname>Sharkey</surname><given-names>LM</given-names></name>, <name><surname>Tufik</surname><given-names>S</given-names></name>, <name><surname>Epstein</surname><given-names>M</given-names></name>, <name><surname>Letts</surname><given-names>VA</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name>, <name><surname>Frankel</surname><given-names>WN</given-names></name>, <name><surname>Escayg</surname><given-names>A</given-names></name></person-group>
<article-title>Heterozygous mutations of the voltage-gated sodium channel SCN8A are associated with spike-wave discharges and absence epilepsy in mice</article-title>. <source>Hum Mol Genet</source>
<year>2009</year>;<volume>18</volume>:<fpage>1633</fpage>â<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp081</pub-id><pub-id pub-id-type="pmid">19254928</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papale</surname><given-names>LA</given-names></name>, <name><surname>Paul</surname><given-names>KN</given-names></name>, <name><surname>Sawyer</surname><given-names>NT</given-names></name>, <name><surname>Manns</surname><given-names>JR</given-names></name>, <name><surname>Tufik</surname><given-names>S</given-names></name>, <name><surname>Escayg</surname><given-names>A</given-names></name></person-group>
<article-title>Dysfunction of the Scn8a voltage-gated sodium channel alters sleep architecture, reduces diurnal corticosterone levels, and enhances spatial memory</article-title>. <source>J Biol Chem</source>
<year>2010</year>;<volume>285</volume>:<fpage>16553</fpage>â<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.090084</pub-id><pub-id pub-id-type="pmid">20353942</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKinney</surname><given-names>BC</given-names></name>, <name><surname>Chow</surname><given-names>CY</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name>, <name><surname>Murphy</surname><given-names>GG</given-names></name></person-group>
<article-title>Exaggerated emotional behavior in mice heterozygous null for the sodium channel Scn8a (Nav1.6)</article-title>. <source>Genes Brain Behav</source>
<year>2008</year>;<volume>7</volume>:<fpage>629</fpage>â<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2008.00399.x</pub-id><pub-id pub-id-type="pmid">18363861</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name>, <name><surname>Wagnon</surname><given-names>JL</given-names></name>, <name><surname>Mahaffey</surname><given-names>CL</given-names></name>, <name><surname>Briese</surname><given-names>M</given-names></name>, <name><surname>Ule</surname><given-names>J</given-names></name>, <name><surname>Frankel</surname><given-names>WN</given-names></name></person-group>
<article-title>Aberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice</article-title>. <source>J Physiol</source>
<year>2013</year>;<volume>591</volume><issue>(Pt 1)</issue>:<fpage>241</fpage>â<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2012.240168</pub-id><pub-id pub-id-type="pmid">23090952</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hargus</surname><given-names>NJ</given-names></name>, <name><surname>Nigam</surname><given-names>A</given-names></name>, <name><surname>Bertram</surname><given-names>EH</given-names><suffix>III</suffix></name>, <name><surname>Patel</surname><given-names>MK</given-names></name></person-group>
<article-title>Evidence for a role of Nav1.6 in facilitating increases in neuronal hyperexcitability during epileptogenesis</article-title>. <source>J Neurophysiol</source>
<year>2013</year>;<volume>110</volume>:<fpage>1144</fpage>â<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00383.2013</pub-id><pub-id pub-id-type="pmid">23741036</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Chen</surname><given-names>L</given-names></name>, <name><surname>Zhou</surname><given-names>J</given-names></name>, <name><surname>Dai</surname><given-names>Q</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Zhou</surname><given-names>L</given-names></name></person-group>
<article-title>Long-term increasing co-localization of SCN8A and ankyrin-G in rat hippocampal cornu ammonis 1 after pilocarpine induced status epilepticus</article-title>. <source>Brain Res</source>
<year>2009</year>;<volume>1270</volume>:<fpage>112</fpage>â<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.03.012</pub-id><pub-id pub-id-type="pmid">19306853</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trudeau</surname><given-names>MM</given-names></name>, <name><surname>Dalton</surname><given-names>JC</given-names></name>, <name><surname>Day</surname><given-names>JW</given-names></name>, <name><surname>Ranum</surname><given-names>LP</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<article-title>Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation</article-title>. <source>J Med Genet</source>
<year>2006</year>;<volume>43</volume>:<fpage>527</fpage>â<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2005.035667</pub-id><pub-id pub-id-type="pmid">16236810</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veeramah</surname><given-names>KR</given-names></name>, <name><surname>O'Brien</surname><given-names>JE</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name>, <name><surname>Cheng</surname><given-names>X</given-names></name>, <name><surname>Dib-Hajj</surname><given-names>SD</given-names></name>, <name><surname>Waxman</surname><given-names>SG</given-names></name>, <name><surname>Talwar</surname><given-names>D</given-names></name>, <name><surname>Girirajan</surname><given-names>S</given-names></name>, <name><surname>Eichler</surname><given-names>EE</given-names></name>, <name><surname>Restifo</surname><given-names>LL</given-names></name>, <name><surname>Erickson</surname><given-names>RP</given-names></name>, <name><surname>Hammer</surname><given-names>MF</given-names></name></person-group>
<article-title>De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP</article-title>. <source>Am J Hum Genet</source>
<year>2012</year>;<volume>90</volume>:<fpage>502</fpage>â<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.01.006</pub-id><pub-id pub-id-type="pmid">22365152</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvill</surname><given-names>GL</given-names></name>, <name><surname>Heavin</surname><given-names>SB</given-names></name>, <name><surname>Yendle</surname><given-names>SC</given-names></name>, <name><surname>McMahon</surname><given-names>JM</given-names></name>, <name><surname>O'Roak</surname><given-names>BJ</given-names></name>, <name><surname>Cook</surname><given-names>J</given-names></name>, <name><surname>Khan</surname><given-names>A</given-names></name>, <name><surname>Dorschner</surname><given-names>MO</given-names></name>, <name><surname>Weaver</surname><given-names>M</given-names></name>, <name><surname>Calvert</surname><given-names>S</given-names></name>, <name><surname>Malone</surname><given-names>S</given-names></name>, <name><surname>Wallace</surname><given-names>G</given-names></name>, <name><surname>Stanley</surname><given-names>T</given-names></name>, <name><surname>Bye</surname><given-names>AM</given-names></name>, <name><surname>Bleasel</surname><given-names>A</given-names></name>, <name><surname>Howell</surname><given-names>KB</given-names></name>, <name><surname>Kivity</surname><given-names>S</given-names></name>, <name><surname>Mackay</surname><given-names>MT</given-names></name>, <name><surname>Rodriguez-Casero</surname><given-names>V</given-names></name>, <name><surname>Webster</surname><given-names>R</given-names></name>, <name><surname>Korczyn</surname><given-names>A</given-names></name>, <name><surname>Afawi</surname><given-names>Z</given-names></name>, <name><surname>Zelnick</surname><given-names>N</given-names></name>, <name><surname>Lerman-Sagie</surname><given-names>T</given-names></name>, <name><surname>Lev</surname><given-names>D</given-names></name>, <name><surname>Moller</surname><given-names>RS</given-names></name>, <name><surname>Gill</surname><given-names>D</given-names></name>, <name><surname>Andrade</surname><given-names>DM</given-names></name>, <name><surname>Freeman</surname><given-names>JL</given-names></name>, <name><surname>Sadleir</surname><given-names>LG</given-names></name>, <name><surname>Shendure</surname><given-names>J</given-names></name>, <name><surname>Berkovic</surname><given-names>SF</given-names></name>, <name><surname>Scheffer</surname><given-names>IE</given-names></name>, <name><surname>Mefford</surname><given-names>HC</given-names></name></person-group>
<article-title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1</article-title>. <source>Nat Genet</source>
<year>2013</year>;<volume>45</volume>:<fpage>825</fpage>â<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2646</pub-id><pub-id pub-id-type="pmid">23708187</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <mixed-citation publication-type="journal"><collab>Epi4K Consortium, Epilepsy Phenome/Genome Project</collab><person-group person-group-type="author"><name><surname>Allen</surname><given-names>AS</given-names></name>, <name><surname>Berkovic</surname><given-names>SF</given-names></name>, <name><surname>Cossette</surname><given-names>P</given-names></name>, <name><surname>Delanty</surname><given-names>N</given-names></name>, <name><surname>Dlugos</surname><given-names>D</given-names></name>, <name><surname>Eichler</surname><given-names>EE</given-names></name>, <name><surname>Epstein</surname><given-names>MP</given-names></name>, <name><surname>Glauser</surname><given-names>T</given-names></name>, <name><surname>Goldstein</surname><given-names>DB</given-names></name>, <name><surname>Han</surname><given-names>Y</given-names></name>, <name><surname>Heinzen</surname><given-names>EL</given-names></name>, <name><surname>Hitomi</surname><given-names>Y</given-names></name>, <name><surname>Howell</surname><given-names>KB</given-names></name>, <name><surname>Johnson</surname><given-names>MR</given-names></name>, <name><surname>Kuzniecky</surname><given-names>R</given-names></name>, <name><surname>Lowenstein</surname><given-names>DH</given-names></name>, <name><surname>Lu</surname><given-names>YF</given-names></name>, <name><surname>Madou</surname><given-names>MR</given-names></name>, <name><surname>Marson</surname><given-names>AG</given-names></name>, <name><surname>Mefford</surname><given-names>HC</given-names></name>, <name><surname>Esmaeeli Nieh</surname><given-names>S</given-names></name>, <name><surname>O'Brien</surname><given-names>TJ</given-names></name>, <name><surname>Ottman</surname><given-names>R</given-names></name>, <name><surname>Petrovski</surname><given-names>S</given-names></name>, <name><surname>Poduri</surname><given-names>A</given-names></name>, <name><surname>Ruzzo</surname><given-names>EK</given-names></name>, <name><surname>Scheffer</surname><given-names>IE</given-names></name>, <name><surname>Sherr</surname><given-names>EH</given-names></name>, <name><surname>Yuskaitis</surname><given-names>CJ</given-names></name>, <name><surname>Abou-Khalil</surname><given-names>B</given-names></name>, <name><surname>Alldredge</surname><given-names>BK</given-names></name>, <name><surname>Bautista</surname><given-names>JF</given-names></name>, <name><surname>Berkovic</surname><given-names>SF</given-names></name>, <name><surname>Boro</surname><given-names>A</given-names></name>, <name><surname>Cascino</surname><given-names>GD</given-names></name>, <name><surname>Consalvo</surname><given-names>D</given-names></name>, <name><surname>Crumrine</surname><given-names>P</given-names></name>, <name><surname>Devinsky</surname><given-names>O</given-names></name>, <name><surname>Dlugos</surname><given-names>D</given-names></name>, <name><surname>Epstein</surname><given-names>MP</given-names></name>, <name><surname>Fiol</surname><given-names>M</given-names></name>, <name><surname>Fountain</surname><given-names>NB</given-names></name>, <name><surname>French</surname><given-names>J</given-names></name>, <name><surname>Friedman</surname><given-names>D</given-names></name>, <name><surname>Geller</surname><given-names>EB</given-names></name>, <name><surname>Glauser</surname><given-names>T</given-names></name>, <name><surname>Glynn</surname><given-names>S</given-names></name>, <name><surname>Haut</surname><given-names>SR</given-names></name>, <name><surname>Hayward</surname><given-names>J</given-names></name>, <name><surname>Helmers</surname><given-names>SL</given-names></name>, <name><surname>Joshi</surname><given-names>S</given-names></name>, <name><surname>Kanner</surname><given-names>A</given-names></name>, <name><surname>Kirsch</surname><given-names>HE</given-names></name>, <name><surname>Knowlton</surname><given-names>RC</given-names></name>, <name><surname>Kossoff</surname><given-names>EH</given-names></name>, <name><surname>Kuperman</surname><given-names>R</given-names></name>, <name><surname>Kuzniecky</surname><given-names>R</given-names></name>, <name><surname>Lowenstein</surname><given-names>DH</given-names></name>, <name><surname>McGuire</surname><given-names>SM</given-names></name>, <name><surname>Motika</surname><given-names>PV</given-names></name>, <name><surname>Novotny</surname><given-names>EJ</given-names></name>, <name><surname>Ottman</surname><given-names>R</given-names></name>, <name><surname>Paolicchi</surname><given-names>JM</given-names></name>, <name><surname>Parent</surname><given-names>JM</given-names></name>, <name><surname>Park</surname><given-names>K</given-names></name>, <name><surname>Poduri</surname><given-names>A</given-names></name>, <name><surname>Scheffer</surname><given-names>IE</given-names></name>, <name><surname>Shellhaas</surname><given-names>RA</given-names></name>, <name><surname>Sherr</surname><given-names>EH</given-names></name>, <name><surname>Shih</surname><given-names>JJ</given-names></name>, <name><surname>Singh</surname><given-names>R</given-names></name>, <name><surname>Sirven</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>MC</given-names></name>, <name><surname>Sullivan</surname><given-names>J</given-names></name>, <name><surname>Lin Thio</surname><given-names>L</given-names></name>, <name><surname>Venkat</surname><given-names>A</given-names></name>, <name><surname>Vining</surname><given-names>EP</given-names></name>, <name><surname>Von Allmen</surname><given-names>GK</given-names></name>, <name><surname>Weisenberg</surname><given-names>JL</given-names></name>, <name><surname>Widdess-Walsh</surname><given-names>P</given-names></name>, <name><surname>Winawer</surname><given-names>MR</given-names></name></person-group>
<article-title>De novo mutations in epileptic encephalopathies</article-title>. <source>Nature</source>
<year>2013</year>;<volume>501</volume>:<fpage>217</fpage>â<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/nature12439</pub-id><pub-id pub-id-type="pmid">23934111</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estacion</surname><given-names>M</given-names></name>, <name><surname>O'Brien</surname><given-names>JE</given-names></name>, <name><surname>Conravey</surname><given-names>A</given-names></name>, <name><surname>Hammer</surname><given-names>MF</given-names></name>, <name><surname>Waxman</surname><given-names>SG</given-names></name>, <name><surname>Dib-Hajj</surname><given-names>SD</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<article-title>A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy</article-title>. <source>Neurobiol Dis</source>
<year>2014</year>;<volume>69</volume>:<fpage>117</fpage>â<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.05.017</pub-id><pub-id pub-id-type="pmid">24874546</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaher</surname><given-names>U</given-names></name>, <name><surname>Noukas</surname><given-names>M</given-names></name>, <name><surname>Nikopensius</surname><given-names>T</given-names></name>, <name><surname>Kals</surname><given-names>M</given-names></name>, <name><surname>Annilo</surname><given-names>T</given-names></name>, <name><surname>Nelis</surname><given-names>M</given-names></name>, <name><surname>Ounap</surname><given-names>K</given-names></name>, <name><surname>Reimand</surname><given-names>T</given-names></name>, <name><surname>Talvik</surname><given-names>I</given-names></name>, <name><surname>Ilves</surname><given-names>P</given-names></name>, <name><surname>Piirsoo</surname><given-names>A</given-names></name>, <name><surname>Seppet</surname><given-names>E</given-names></name>, <name><surname>Metspalu</surname><given-names>A</given-names></name>, <name><surname>Talvik</surname><given-names>T</given-names></name></person-group>
<article-title>De Novo SCN8A mutation identified by whole-exome sequencing in a boy with neonatal epileptic encephalopathy, multiple congenital anomalies, and movement disorders</article-title>. <source>J Child Neurol</source>
<year>2014</year>;<volume>29</volume>:<fpage>NP202</fpage>â<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1177/0883073813511300</pub-id><pub-id pub-id-type="pmid">24352161</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohba</surname><given-names>C</given-names></name>, <name><surname>Kato</surname><given-names>M</given-names></name>, <name><surname>Takahashi</surname><given-names>S</given-names></name>, <name><surname>Lerman-Sagie</surname><given-names>T</given-names></name>, <name><surname>Lev</surname><given-names>D</given-names></name>, <name><surname>Terashima</surname><given-names>H</given-names></name>, <name><surname>Kubota</surname><given-names>M</given-names></name>, <name><surname>Kawawaki</surname><given-names>H</given-names></name>, <name><surname>Matsufuji</surname><given-names>M</given-names></name>, <name><surname>Kojima</surname><given-names>Y</given-names></name>, <name><surname>Tateno</surname><given-names>A</given-names></name>, <name><surname>Goldberg-Stern</surname><given-names>H</given-names></name>, <name><surname>Straussberg</surname><given-names>R</given-names></name>, <name><surname>Marom</surname><given-names>D</given-names></name>, <name><surname>Leshinsky-Silver</surname><given-names>E</given-names></name>, <name><surname>Nakashima</surname><given-names>M</given-names></name>, <name><surname>Nishiyama</surname><given-names>K</given-names></name>, <name><surname>Tsurusaki</surname><given-names>Y</given-names></name>, <name><surname>Miyake</surname><given-names>N</given-names></name>, <name><surname>Tanaka</surname><given-names>F</given-names></name>, <name><surname>Matsumoto</surname><given-names>N</given-names></name>, <name><surname>Saitsu</surname><given-names>H</given-names></name></person-group>
<article-title>Early onset epileptic encephalopathy caused by de novo SCN8A mutations</article-title>. <source>Epilepsia</source>
<year>2014</year>;<volume>55</volume>:<fpage>994</fpage>â<lpage>1000</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12668</pub-id><pub-id pub-id-type="pmid">24888894</pub-id></mixed-citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>J</given-names></name>, <name><surname>Carvill</surname><given-names>GL</given-names></name>, <name><surname>Gardella</surname><given-names>E</given-names></name>, <name><surname>Kluger</surname><given-names>G</given-names></name>, <name><surname>Schmiedel</surname><given-names>G</given-names></name>, <name><surname>Barisic</surname><given-names>N</given-names></name>, <name><surname>Depienne</surname><given-names>C</given-names></name>, <name><surname>Brilstra</surname><given-names>E</given-names></name>, <name><surname>Mang</surname><given-names>Y</given-names></name>, <name><surname>Nielsen</surname><given-names>JE</given-names></name>, <name><surname>Kirkpatrick</surname><given-names>M</given-names></name>, <name><surname>Goudie</surname><given-names>D</given-names></name>, <name><surname>Goldman</surname><given-names>R</given-names></name>, <name><surname>JÃ¤hn</surname><given-names>JA</given-names></name>, <name><surname>Jepsen</surname><given-names>B</given-names></name>, <name><surname>Gill</surname><given-names>D</given-names></name>, <name><surname>DÃ¶cker</surname><given-names>M</given-names></name>, <name><surname>Biskup</surname><given-names>S</given-names></name>, <name><surname>McMahon</surname><given-names>JM</given-names></name>, <name><surname>Koeleman</surname><given-names>B</given-names></name>, <name><surname>Harris</surname><given-names>M</given-names></name>, <name><surname>Braun</surname><given-names>K</given-names></name>, <name><surname>de Kovel</surname><given-names>CG</given-names></name>, <name><surname>Marini</surname><given-names>C</given-names></name>, <name><surname>Specchio</surname><given-names>N</given-names></name>, <name><surname>DjÃ©miÃ©</surname><given-names>T</given-names></name>, <name><surname>Weckhuysen</surname><given-names>S</given-names></name>, <name><surname>Tommerup</surname><given-names>N</given-names></name>, <name><surname>Troncoso</surname><given-names>M</given-names></name>, <name><surname>Troncoso</surname><given-names>L</given-names></name>, <collab>EuroEPINOMICS RES CRP</collab>, <name><surname>Bevot</surname><given-names>A</given-names></name>, <name><surname>Wolff</surname><given-names>M</given-names></name>, <name><surname>Hjalgrim</surname><given-names>H</given-names></name>, <name><surname>Guerrini</surname><given-names>R</given-names></name>, <name><surname>Scheffer</surname><given-names>IE</given-names></name>, <name><surname>Mefford</surname><given-names>HC</given-names></name>, <name><surname>MÃ¸ller</surname><given-names>RS</given-names></name></person-group>
<article-title>The phenotypic spectrum of SCN8A encephalopathy</article-title>. <source>Neurology</source>
<year>2015</year>;<volume>84</volume>:<fpage>480</fpage>â<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000001211</pub-id><pub-id pub-id-type="pmid">25568300</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Kovel</surname><given-names>CG</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name>, <name><surname>Brilstra</surname><given-names>EH</given-names></name>, <name><surname>van Berkestijn</surname><given-names>FM</given-names></name>, <name><surname>Slot</surname><given-names>RV</given-names></name>, <name><surname>van Lieshout</surname><given-names>S</given-names></name>, <name><surname>Nijman</surname><given-names>IJ</given-names></name>, <name><surname>O'Brien</surname><given-names>JE</given-names></name>, <name><surname>Hammer</surname><given-names>MF</given-names></name>, <name><surname>Estacion</surname><given-names>M</given-names></name>, <name><surname>Waxman</surname><given-names>SG</given-names></name>, <name><surname>Dib-Hajj</surname><given-names>SD</given-names></name>, <name><surname>Koeleman</surname><given-names>BP</given-names></name></person-group>
<article-title>Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy</article-title>. <source>Epilepsy Res</source>
<year>2014</year>;<volume>108</volume>:<fpage>1511</fpage>â<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2014.08.020</pub-id><pub-id pub-id-type="pmid">25239001</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Ligt</surname><given-names>J</given-names></name>, <name><surname>Willemsen</surname><given-names>MH</given-names></name>, <name><surname>van Bon</surname><given-names>BW</given-names></name>, <name><surname>Kleefstra</surname><given-names>T</given-names></name>, <name><surname>Yntema</surname><given-names>HG</given-names></name>, <name><surname>Kroes</surname><given-names>T</given-names></name>, <name><surname>Vulto-van Silfhout</surname><given-names>AT</given-names></name>, <name><surname>Koolen</surname><given-names>DA</given-names></name>, <name><surname>de Vries</surname><given-names>P</given-names></name>, <name><surname>Gilissen</surname><given-names>C</given-names></name>, <name><surname>del Rosario</surname><given-names>M</given-names></name>, <name><surname>Hoischen</surname><given-names>A</given-names></name>, <name><surname>Scheffer</surname><given-names>H</given-names></name>, <name><surname>de Vries</surname><given-names>BB</given-names></name>, <name><surname>Brunner</surname><given-names>HG</given-names></name>, <name><surname>Veltman</surname><given-names>JA</given-names></name>, <name><surname>Vissers</surname><given-names>LE</given-names></name></person-group>
<article-title>Diagnostic exome sequencing in persons with severe intellectual disability</article-title>. <source>N Engl J Med</source>
<year>2012</year>;<volume>367</volume>:<fpage>1921</fpage>â<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1206524</pub-id><pub-id pub-id-type="pmid">23033978</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vissers</surname><given-names>LE</given-names></name>, <name><surname>de Ligt</surname><given-names>J</given-names></name>, <name><surname>Gilissen</surname><given-names>C</given-names></name>, <name><surname>Janssen</surname><given-names>I</given-names></name>, <name><surname>Steehouwer</surname><given-names>M</given-names></name>, <name><surname>de Vries</surname><given-names>P</given-names></name>, <name><surname>van Lier</surname><given-names>B</given-names></name>, <name><surname>Arts</surname><given-names>P</given-names></name>, <name><surname>Wieskamp</surname><given-names>N</given-names></name>, <name><surname>del Rosario</surname><given-names>M</given-names></name>, <name><surname>van Bon</surname><given-names>BW</given-names></name>, <name><surname>Hoischen</surname><given-names>A</given-names></name>, <name><surname>de Vries</surname><given-names>BB</given-names></name>, <name><surname>Brunner</surname><given-names>HG</given-names></name>, <name><surname>Veltman</surname><given-names>JA</given-names></name></person-group>
<article-title>A de novo paradigm for mental retardation</article-title>. <source>Nat Genet</source>
<year>2010</year>;<volume>42</volume>:<fpage>1109</fpage>â<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/ng.712</pub-id><pub-id pub-id-type="pmid">21076407</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neveling</surname><given-names>K</given-names></name>, <name><surname>Feenstra</surname><given-names>I</given-names></name>, <name><surname>Gilissen</surname><given-names>C</given-names></name>, <name><surname>Hoefsloot</surname><given-names>LH</given-names></name>, <name><surname>Kamsteeg</surname><given-names>EJ</given-names></name>, <name><surname>Mensenkamp</surname><given-names>AR</given-names></name>, <name><surname>Rodenburg</surname><given-names>RJ</given-names></name>, <name><surname>Yntema</surname><given-names>HG</given-names></name>, <name><surname>Spruijt</surname><given-names>L</given-names></name>, <name><surname>Vermeer</surname><given-names>S</given-names></name>, <name><surname>Rinne</surname><given-names>T</given-names></name>, <name><surname>van Gassen</surname><given-names>KL</given-names></name>, <name><surname>Bodmer</surname><given-names>D</given-names></name>, <name><surname>Lugtenberg</surname><given-names>D</given-names></name>, <name><surname>de Reuver</surname><given-names>R</given-names></name>, <name><surname>Buijsman</surname><given-names>W</given-names></name>, <name><surname>Derks</surname><given-names>RC</given-names></name>, <name><surname>Wieskamp</surname><given-names>N</given-names></name>, <name><surname>van den Heuvel</surname><given-names>B</given-names></name>, <name><surname>Ligtenberg</surname><given-names>MJ</given-names></name>, <name><surname>Kremer</surname><given-names>H</given-names></name>, <name><surname>Koolen</surname><given-names>DA</given-names></name>, <name><surname>van de Warrenburg</surname><given-names>BP</given-names></name>, <name><surname>Cremers</surname><given-names>FP</given-names></name>, <name><surname>Marcelis</surname><given-names>CL</given-names></name>, <name><surname>Smeitink</surname><given-names>JA</given-names></name>, <name><surname>Wortmann</surname><given-names>SB</given-names></name>, <name><surname>van Zelst-Stams</surname><given-names>WA</given-names></name>, <name><surname>Veltman</surname><given-names>JA</given-names></name>, <name><surname>Brunner</surname><given-names>HG</given-names></name>, <name><surname>Scheffer</surname><given-names>H</given-names></name>, <name><surname>Nelen</surname><given-names>MR</given-names></name></person-group>
<article-title>A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases</article-title>. <source>Hum Mutat</source>
<year>2013</year>;<volume>34</volume>:<fpage>1721</fpage>â<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22450</pub-id><pub-id pub-id-type="pmid">24123792</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzog</surname><given-names>RI</given-names></name>, <name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Waxman</surname><given-names>SG</given-names></name>, <name><surname>Cummins</surname><given-names>TR</given-names></name></person-group>
<article-title>Calmodulin binds to the C terminus of sodium channels Nav1.4 and Nav1.6 and differentially modulates their functional properties</article-title>. <source>J Neurosci</source>
<year>2003</year>;<volume>23</volume>:<fpage>8261</fpage>â<lpage>70</lpage>.<pub-id pub-id-type="pmid">12967988</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Yarov-Yarovoy</surname><given-names>V</given-names></name>, <name><surname>Scheuer</surname><given-names>T</given-names></name>, <name><surname>Catterall</surname><given-names>WA</given-names></name></person-group>
<article-title>A gating hinge in Na+ channels; a molecular switch for electrical signaling</article-title>. <source>Neuron</source>
<year>2004</year>;<volume>41</volume>:<fpage>859</fpage>â<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(04)00116-3</pub-id><pub-id pub-id-type="pmid">15046719</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brackenbury</surname><given-names>WJ</given-names></name>, <name><surname>Calhoun</surname><given-names>JD</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Miyazaki</surname><given-names>H</given-names></name>, <name><surname>Nukina</surname><given-names>N</given-names></name>, <name><surname>Oyama</surname><given-names>F</given-names></name>, <name><surname>Ranscht</surname><given-names>B</given-names></name>, <name><surname>Isom</surname><given-names>LL</given-names></name></person-group>
<article-title>Functional reciprocity between Na+ channel Nav1.6 and beta1 subunits in the coordinated regulation of excitability and neurite outgrowth</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2010</year>;<volume>107</volume>:<fpage>2283</fpage>â<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0909434107</pub-id><pub-id pub-id-type="pmid">20133873</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cestele</surname><given-names>S</given-names></name>, <name><surname>Schiavon</surname><given-names>E</given-names></name>, <name><surname>Rusconi</surname><given-names>R</given-names></name>, <name><surname>Franceschetti</surname><given-names>S</given-names></name>, <name><surname>Mantegazza</surname><given-names>M</given-names></name></person-group>
<article-title>Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2013</year>;<volume>110</volume>:<fpage>17546</fpage>â<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1309827110</pub-id><pub-id pub-id-type="pmid">24101488</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharkey</surname><given-names>LM</given-names></name>, <name><surname>Jones</surname><given-names>JM</given-names></name>, <name><surname>Hedera</surname><given-names>P</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<article-title>Evaluation of SCN8A as a candidate gene for autosomal dominant essential tremor</article-title>. <source>Parkinsonism Relat Disord</source>
<year>2009</year>;<volume>15</volume>:<fpage>321</fpage>â<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2008.06.010</pub-id><pub-id pub-id-type="pmid">18718804</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>JE</given-names></name>, <name><surname>Sharkey</surname><given-names>LM</given-names></name>, <name><surname>Vallianatos</surname><given-names>CN</given-names></name>, <name><surname>Han</surname><given-names>C</given-names></name>, <name><surname>Blossom</surname><given-names>JC</given-names></name>, <name><surname>Yu</surname><given-names>T</given-names></name>, <name><surname>Waxman</surname><given-names>SG</given-names></name>, <name><surname>Dib-Hajj</surname><given-names>SD</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name></person-group>
<article-title>Interaction of voltage-gated sodium channel Nav1.6 (SCN8A) with microtubule-associated protein Map1b</article-title>. <source>J Biol Chem</source>
<year>2012</year>;<volume>287</volume>:<fpage>18459</fpage>â<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.336024</pub-id><pub-id pub-id-type="pmid">22474336</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name>, <name><surname>Dib-Hajj</surname><given-names>S</given-names></name>, <name><surname>Meisler</surname><given-names>MH</given-names></name>, <name><surname>Pietrobon</surname><given-names>D</given-names></name></person-group>
<article-title>Inherited neuronal ion channelopathies: new windows on complex neurological diseases</article-title>. <source>J Neurosci</source>
<year>2008</year>;<volume>28</volume>:<fpage>11768</fpage>â<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3901-08.2008</pub-id><pub-id pub-id-type="pmid">19005038</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceulemans</surname><given-names>BP</given-names></name>, <name><surname>Claes</surname><given-names>LR</given-names></name>, <name><surname>Lagae</surname><given-names>LG</given-names></name></person-group>
<article-title>Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy</article-title>. <source>Pediatr Neurol</source>
<year>2004</year>;<volume>30</volume>:<fpage>236</fpage>â<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2003.10.012</pub-id><pub-id pub-id-type="pmid">15087100</pub-id></mixed-citation>
      </ref>
      <ref id="R44">
        <label>44</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliva</surname><given-names>M</given-names></name>, <name><surname>Berkovic</surname><given-names>SF</given-names></name>, <name><surname>Petrou</surname><given-names>S</given-names></name></person-group>
<article-title>Sodium channels and the neurobiology of epilepsy</article-title>. <source>Epilepsia</source>
<year>2012</year>;<volume>53</volume>:<fpage>1849</fpage>â<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03631.x</pub-id><pub-id pub-id-type="pmid">22905747</pub-id></mixed-citation>
      </ref>
      <ref id="R45">
        <label>45</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>C</given-names></name>, <name><surname>Abe</surname><given-names>Y</given-names></name>, <name><surname>Westenbroek</surname><given-names>RE</given-names></name>, <name><surname>Scheuer</surname><given-names>T</given-names></name>, <name><surname>Catterall</surname><given-names>WA</given-names></name></person-group>
<article-title>Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2014</year>;<volume>111</volume>:<fpage>E3139</fpage>â<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1411131111</pub-id><pub-id pub-id-type="pmid">25024183</pub-id></mixed-citation>
      </ref>
      <ref id="R46">
        <label>46</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalume</surname><given-names>F</given-names></name>, <name><surname>Westenbroek</surname><given-names>RE</given-names></name>, <name><surname>Cheah</surname><given-names>CS</given-names></name>, <name><surname>Yu</surname><given-names>FH</given-names></name>, <name><surname>Oakley</surname><given-names>JC</given-names></name>, <name><surname>Scheuer</surname><given-names>T</given-names></name>, <name><surname>Catterall</surname><given-names>WA</given-names></name></person-group>
<article-title>Sudden unexpected death in a mouse model of Dravet syndrome</article-title>. <source>J Clin Invest</source>
<year>2013</year>;<volume>123</volume>:<fpage>1798</fpage>â<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1172/JCI66220</pub-id><pub-id pub-id-type="pmid">23524966</pub-id></mixed-citation>
      </ref>
      <ref id="R47">
        <label>47</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogiwara</surname><given-names>I</given-names></name>, <name><surname>Iwasato</surname><given-names>T</given-names></name>, <name><surname>Miyamoto</surname><given-names>H</given-names></name>, <name><surname>Iwata</surname><given-names>R</given-names></name>, <name><surname>Yamagata</surname><given-names>T</given-names></name>, <name><surname>Mazaki</surname><given-names>E</given-names></name>, <name><surname>Yanagawa</surname><given-names>Y</given-names></name>, <name><surname>Tamamaki</surname><given-names>N</given-names></name>, <name><surname>Hensch</surname><given-names>TK</given-names></name>, <name><surname>Itohara</surname><given-names>S</given-names></name>, <name><surname>Yamakawa</surname><given-names>K</given-names></name></person-group>
<article-title>Nav1.1 haploinsufficiency in excitatory neurons ameliorates seizure-associated sudden death in a mouse model of Dravet syndrome</article-title>. <source>Hum Mol Genet</source>
<year>2013</year>;<volume>22</volume>:<fpage>4784</fpage>â<lpage>804</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt331</pub-id><pub-id pub-id-type="pmid">23922229</pub-id></mixed-citation>
      </ref>
      <ref id="R48">
        <label>48</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkin</surname><given-names>MA</given-names></name>, <name><surname>Blackshields</surname><given-names>G</given-names></name>, <name><surname>Brown</surname><given-names>NP</given-names></name>, <name><surname>Chenna</surname><given-names>R</given-names></name>, <name><surname>McGettigan</surname><given-names>PA</given-names></name>, <name><surname>McWilliam</surname><given-names>H</given-names></name>, <name><surname>Valentin</surname><given-names>F</given-names></name>, <name><surname>Wallace</surname><given-names>IM</given-names></name>, <name><surname>Wilm</surname><given-names>A</given-names></name>, <name><surname>Lopez</surname><given-names>R</given-names></name>, <name><surname>Thompson</surname><given-names>JD</given-names></name>, <name><surname>Gibson</surname><given-names>TJ</given-names></name>, <name><surname>Higgins</surname><given-names>DG</given-names></name></person-group>
<article-title>Clustal W and Clustal X version 2.0</article-title>. <source>Bioinformatics</source>
<year>2007</year>;<volume>23</volume>:<fpage>2947</fpage>â<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id><pub-id pub-id-type="pmid">17846036</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>